Skip to main content

Table 7 Changes of NLR in patients of response and non-response groups

From: Correction to: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

Group

Trend

Decrease

Increase

Total

Response

36

52

88

Non-response

14

17

31

Total

50

69

119

P value

0.679

  
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us